Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung
- PMID: 2449084
- PMCID: PMC1880523
Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung
Abstract
In order to differentiate between malignant pleural mesothelioma and adenocarcinoma of the lung, the glycoconjugate profiles of 6 reactive mesothelial lesions, 23 mesotheliomas (17 epithelial, 1 desmoplastic, 2 biphasic, and 3 fibrous types), and 28 well-differentiated pulmonary adenocarcinomas were evaluated with the use of 8 lectins in addition to anti-carcinoembryonic, anti-keratin and anti-epithelial membrane antigen. Formalin-fixed, paraffin-embedded tissues were stained with the avidin-biotin peroxidase complex method. Reactions of wheat germ (WGA) and peanut (PNA) agglutinin with neuraminidase treatment lectins were positive in 5 of 6 (83%) and 3 of 6 (50%) cases, respectively, in reactive mesothelial lesions. Thirteen of 23 (57%) malignant mesotheliomas of the pleura showed a positive reaction for WGA and PNA with neuraminidase treatment; other lectins were low-positive, below 9%. In contrast, pulmonary adenocarcinomas showed positive reactions in 27 of 28 cases (96%) for PNA, 26 of 28 (93%) for Ricinus communis (RCA-I), 25 of 28 (89%) for WGA, and 22 of 28 (79%) for succinylated WGA (SucWGA). The findings suggest that malignant pleural mesothelioma and pulmonary adenocarcinoma have consistent and distinct glycoconjugate profiles, and that stains for RCA-I and SucWGA may be useful for differential diagnosis.
Similar articles
-
Expression of blood group-related antigens and Helix pomatia agglutinin in malignant pleural mesothelioma and pulmonary adenocarcinoma.Hum Pathol. 1991 Feb;22(2):118-24. doi: 10.1016/0046-8177(91)90032-k. Hum Pathol. 1991. PMID: 2001875
-
Lectin histochemistry of normal lung and pulmonary adenocarcinoma.Mod Pathol. 1988 Nov;1(6):485-92. Mod Pathol. 1988. PMID: 3222257
-
Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.Am J Pathol. 1986 May;123(2):212-9. Am J Pathol. 1986. PMID: 2422942 Free PMC article.
-
Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.Am J Clin Pathol. 1998 Jan;109(1):85-9. doi: 10.1093/ajcp/109.1.85. Am J Clin Pathol. 1998. PMID: 9426522 Review.
-
Pleural neoplastic pathology.Respir Med. 2015 Aug;109(8):931-43. doi: 10.1016/j.rmed.2015.05.014. Epub 2015 May 21. Respir Med. 2015. PMID: 26048082 Review.
Cited by
-
Malignant pleural mesothelioma diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.Tuberc Respir Dis (Seoul). 2013 Feb;74(2):74-8. doi: 10.4046/trd.2013.74.2.74. Epub 2013 Feb 28. Tuberc Respir Dis (Seoul). 2013. PMID: 23483811 Free PMC article.
-
Blood group antigens, Lewisx and Lewisy in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma.Am J Pathol. 1989 Nov;135(5):931-7. Am J Pathol. 1989. PMID: 2817084 Free PMC article.
-
Diagnostic tests in pleural effusion--an update.Postgrad Med J. 1993 Jan;69(807):12-8. doi: 10.1136/pgmj.69.807.12. Postgrad Med J. 1993. PMID: 8446546 Free PMC article. Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical